Lanzone A

No ORCID on file · 9 papers in corpus · active 1990-2025

Study types

  • article 6

Condition tags

  • endometriosis 6
2025
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.15050

IntroductionRecurrent pregnancy loss (RPL), defined as two or more consecutive pregnancy losses before 24 weeks of gestation, affects up to 1%-2% of couples. Aim of this retrospective cohort study was to report the main causes and pregnancy…

2024
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-024-01491-1

Placenta accreta spectrum (PAS) refers to excessive placental invasion into the maternal uterus and it is associated with high risk of obstetric haemorrhage and adverse maternal-neonatal outcomes. Currently, no specific circulating biomarke…

2022
Facts, views & vision in ObGyn ·doi:10.52054/fvvo.14.2.020

Hysteroscopic uterine evacuation of early pregnancy loss using tissue removal devices seems to be a safe and feasible procedure in selected cases. The hysteroscopic approach allows the precise localisation of the gestational sac inside the …

article 1999
Rays

After an overview of normal ovarian morphology assessed during diagnostic laparoscopy, the typical patterns most frequently associated to ovarian factor sterility, observed in gonadal dysgenesis and dysfunction syndromes as LUF or follicula…

article 1992
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.3109/09513599209024989

Serum levels of CA-125, CA-15-3 and TAG-72 were measured in 81 patients with endometriosis, diagnosed by laparoscopy, and staged according to the Revised American Fertility Society, and in 31 control subjects. The values of CA-125 and CA-15…

article 1992
article 1991
article 1991
The Journal of reproductive medicine

The value of CA-125 for the diagnosis and management of endometriosis (EN) was investigated by assaying the marker in the serum and peritoneal fluid (PF) from patients with the disease in comparison with control subjects. Of women who under…

article 1990
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1990.tb02474.x

Twenty-two women with endometriosis were treated with the luteinizing hormone-releasing hormone (LHRH) agonist buserelin for 6 months. At second-look laparoscopy the mean score of endometriosis had decreased from 23.1 (SD 17.0) to 17.2 (SD …